Cancer Advances Inc.
Cancer Advances, a subsidiary of Cato Bioventures, develops immunomodulator therapeutics to treat gastrointestinal cancers.
Company Location
4364 S. Alston Ave., Suite 210
Durham
NC
27713
Phone
County
Region
Company Details
Company type
Year founded
2008
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products under development
Polyclonal Antibody Stimulator (PAS); G17DT